Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma

The purpose of this study is to determine whether concurrent chemotherapy and IMRT is effective in the treatment of locally stage T3/T4 recurrent nasopharyngeal carcinoma patients compared with IMRT alone.

NCT Number	NCT04136886
Lead Sponsor	Sun Yat-sen University Collaborators: JiangXi Province Tumor Hospital, Fujian Province Tumor Hospital, SiChuan Province Tumor Hospital, Hunan Province Tumor Hospital, YuNan Province Tumor Hospital, GuiZhou Province Tumor Hospital, Hainan Cancer Hospital, Tongji Hospital, Second Affiliated Hospital of Nanchang University, Wuhan University, First Hospital of FoShan City
Conditions	Nasopharyngeal Carcinoma
Enrollment	346 participants
Start Date	2020-01-01
Primary Completion	2027-12 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2019-10-23